Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy, safety, and tolerability of vibegron in men with overactive bladder on BPH therapy has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Overactive Bladder

Drugs mentioned

• Vibegron (vibegron)

Snippet

Sponsor: Urovant Sciences GmbH | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2024-08-07